U.S. flag

An official website of the United States government

NM_012330.4(KAT6B):c.3289GAA[9] (p.Glu1104dup) AND not specified

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Aug 28, 2017
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000246745.13

Allele description [Variation Report for NM_012330.4(KAT6B):c.3289GAA[9] (p.Glu1104dup)]

NM_012330.4(KAT6B):c.3289GAA[9] (p.Glu1104dup)

Gene:
KAT6B:lysine acetyltransferase 6B [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
10q22.2
Genomic location:
Preferred name:
NM_012330.4(KAT6B):c.3289GAA[9] (p.Glu1104dup)
HGVS:
  • NC_000010.11:g.75022148GAA[9]
  • NG_032048.1:g.200736GAA[9]
  • NM_001256468.2:c.2740GAA[9]
  • NM_001256469.2:c.2413GAA[9]
  • NM_001370132.1:c.2251GAA[9]
  • NM_001370133.1:c.1600GAA[9]
  • NM_001370134.1:c.1204GAA[9]
  • NM_001370135.1:c.946GAA[9]
  • NM_001370136.1:c.3289GAA[9]
  • NM_001370137.1:c.3289GAA[9]
  • NM_001370138.1:c.2740GAA[9]
  • NM_001370139.1:c.2413GAA[9]
  • NM_001370140.1:c.2413GAA[9]
  • NM_001370141.1:c.2413GAA[9]
  • NM_001370142.1:c.2413GAA[9]
  • NM_001370143.1:c.2224GAA[9]
  • NM_001370144.1:c.2224GAA[9]
  • NM_012330.4:c.3289GAA[9]MANE SELECT
  • NP_001243397.1:p.Glu921dup
  • NP_001243398.1:p.Glu812dup
  • NP_001357061.1:p.Glu758dup
  • NP_001357062.1:p.Glu541dup
  • NP_001357063.1:p.Glu409dup
  • NP_001357064.1:p.Glu323dup
  • NP_001357065.1:p.Glu1104dup
  • NP_001357066.1:p.Glu1104dup
  • NP_001357067.1:p.Glu921dup
  • NP_001357068.1:p.Glu812dup
  • NP_001357069.1:p.Glu812dup
  • NP_001357070.1:p.Glu812dup
  • NP_001357071.1:p.Glu812dup
  • NP_001357072.1:p.Glu749dup
  • NP_001357073.1:p.Glu749dup
  • NP_036462.2:p.Glu1104dup
  • NC_000010.10:g.76781905_76781906insGAA
  • NC_000010.10:g.76781906GAA[9]
  • NM_012330.3:c.3310_3312dup
  • NM_012330.3:c.3310_3312dupGAA
Links:
dbSNP: rs71929101
NCBI 1000 Genomes Browser:
rs71929101
Molecular consequence:
  • NM_001256468.2:c.2740GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001256469.2:c.2413GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370132.1:c.2251GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370133.1:c.1600GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370134.1:c.1204GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370135.1:c.946GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370136.1:c.3289GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370137.1:c.3289GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370138.1:c.2740GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370139.1:c.2413GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370140.1:c.2413GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370141.1:c.2413GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370142.1:c.2413GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370143.1:c.2224GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001370144.1:c.2224GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_012330.4:c.3289GAA[9] - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000311909PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benigngermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000864360Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(Aug 28, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001965923Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Benigngermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV000311909.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital, SCV000864360.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

BS1, BS2, BP3; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, and is an in-frame deletion/insertion in a repetitive region without a known function.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus, SCV001965923.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024